Search

A recent report from Arak University discusses research on anxiolytics, sedatives, and hypnotics, focusing on the interaction of the drugs buspirone and sertraline with human serum albumin. The study utilized spectroscopic and molecular modeling techniques to investigate the binding affinity and structural changes caused by these drugs on human serum albumin. The findings suggest that both buspirone and sertraline have a strong ability to interact with human serum albumin through hydrophobic interactions, van der Waals forces, and hydrogen bonds. The research highlights the impact of co-administering these drugs on their binding affinity to human serum albumin. [Extracted from the article]

Researchers from the University of Mississippi have conducted a study on urinary tract infections (UTIs) caused by Uropathogenic Escherichia coli (UPEC). They used computer-aided drug design techniques to identify novel glycomimetics that can inhibit the UPEC FmlH protein, which is responsible for bacterial attachment to host cells. The study resulted in the creation of 58 novel glycomimetics with potential for further biological activity studies, aiming to provide alternative therapeutic approaches to UTIs. The research was funded by the National Institutes of Health and published in the journal Applied Sciences. [Extracted from the article]

A recent report from Shaanxi University of Chinese Medicine discusses the development of mIDH1 inhibitors using deep learning and molecular modeling techniques. Mutations in the IDH1 gene are significant in the development of certain cancers, making it a promising target for therapy. The study generated new compounds using bidirectional recurrent neural network and scaffold hopping methods, identifying compound M1 as the most promising candidate with optimal binding properties. This research provides theoretical guidance for the design of mIDH1 inhibitors, showcasing the potential of deep learning in drug development. [Extracted from the article]

A recent report from the University of Genoa discusses the discovery of novel thiazole-based SIRT2 inhibitors as potential anticancer agents. The research focuses on the development of effective sirtuin small molecule inhibitors for various pharmacological applications, including cancer therapy. Through molecular modeling, chemical synthesis, and biological assays, the study identified compound 5a as a promising SIRT2 inhibitor with potential for further development as an anticancer agent. This research sheds light on the ongoing efforts to find new and more selective modulators for combating cancer and other diseases. [Extracted from the article]

A recent study conducted at the University of Cape Coast in Ghana focused on evaluating the potential of antibacterial peptides to target the interprotofilament interface of the bacterial actin MreB. Through molecular modeling and simulations, researchers identified two peptides, Pep4 and Pep7, as promising inhibitors that could disrupt MreB-MreB interactions and impede the polymerization process. These findings suggest that Pep4 and Pep7 could serve as leads for the development of peptide-based antibiotics targeting MreB. The research has been peer-reviewed and offers valuable insights into combating bacterial infections and resistance. [Extracted from the article]

A study conducted at the University of Sidi Mohamed Ben Abdellah in Fes, Morocco, focused on the synthesis, characterization, and antibacterial activity of novel chromone-isoxazole hybrids. The research involved the use of spectroscopy techniques, mass spectrometry, Density Functional Theory (DFT) calculations, and molecular docking studies to evaluate the compounds. The findings indicated that some compounds showed promising antibacterial efficacy and good pharmacokinetic profiles, with minimal signs of toxicity. The research has been peer-reviewed and provides valuable insights into potential new antibiotics. [Extracted from the article]

Researchers at Islamia University Bahawalpur in Punjab, Pakistan have conducted a study on the potential therapeutic effects of Schiff base derivatives of amlodipine, a calcium channel blocking agent. The derivatives were tested for their urease inhibition, antibacterial, and antioxidant activities. The compounds showed promising results and could serve as leads for further investigations. The research was supported by King Saud University and has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at the University of Gafsa in Tunisia explores the use of organoclays as a drug carrier for metformin, an antidiabetic agent. The study combines experimental and computational modeling techniques to investigate the advantages of using a Tunisian clay for drug delivery applications. The results show that the clays are capable of adsorbing metformin, with a maximum load of 12.42% and 21.97% for different types of clays. The study suggests that these clays could be used as carriers in controlled drug delivery for future clinical applications. [Extracted from the article]

A recent study conducted by researchers at the University of Guilan in Rasht, Iran, explored the interaction between alpha casein (alpha-CN) and two antihyperlipidemic drugs, fluvastatin (FLU) and pitavastatin (PIT). The study utilized fluorescence, UV absorption, and FTIR techniques, as well as molecular modeling, to investigate the binding of these drugs to alpha-CN. The results indicated that both FLU and PIT bind to alpha-CN, with PIT exhibiting a higher binding affinity. The study suggests that alpha-CN may act as a carrier for FLU and PIT drugs. This research has been peer-reviewed and published in the Journal of Structural Chemistry. [Extracted from the article]

A recent study conducted at the State University of New York (SUNY) Stony Brook has explored the use of a small molecule agonist of Kruppel-like Factor 15 (KLF15) in proteinuric kidney disease. The researchers found that the agonist, called BT503, demonstrated protective effects in human podocytes and proteinuric murine models. The study suggests that BT503 works by inhibiting the inhibitor of nuclear factor kappa-B kinase subunit beta, which restores KLF15 and rescues podocyte loss, thereby ameliorating kidney injury. This research provides valuable insights into potential therapeutic approaches for glomerular diseases. [Extracted from the article]

A recent study conducted at Y.B. Chavan College of Pharmacy in Maharashtra, India, focused on the design, synthesis, biological evaluation, and molecular modeling of new aminopyrimidine derivatives as potential anticancer agents. The researchers developed efficient 2-aminopyrimidine derivatives and tested their anticancer activity against colon cancer cell lines. Two compounds, SD2 and SD4, showed potent anticancer activity comparable to the standard drug Cabozantinib. Molecular docking and dynamic simulation further supported the findings. This research provides valuable insights into the development of new anticancer agents. [Extracted from the article]

Researchers from Hazara University in Mansehra, Pakistan have conducted a study on piperazine therapy. They synthesized piperazine-based bis-Schiff base derivatives and tested their inhibition against urease enzyme. Among the tested analogs, analog 2 showed the highest potency with the lowest IC50 value, while scaffold 5 had the lowest activity. The researchers also used molecular docking to investigate the binding interactions of the active compounds with the targeted urease enzyme. This research has been peer-reviewed and provides promising insights into the development of anti-urease agents. [Extracted from the article]

Researchers at King Abdulaziz University in Jeddah, Saudi Arabia have conducted a study on cancer treatment targeting the phosphoinositide 3-kinase (PI3K) signaling pathway. Using computational methods, the researchers identified a novel inhibitor for the gene PIK3CG, which encodes the catalytic subunit gamma of PI3K gamma. Through screening and modeling, they found that one compound, 885,387, showed significant therapeutic potential as an inhibitor of the PIK3CG target implicated in cancer. Further experimental investigation is warranted. This research has been peer-reviewed and published in Molecular Diversity. [Extracted from the article]

Researchers from Jazan University in Saudi Arabia have conducted a study on bacterial infections expressing New Delhi metallo-lactamase-1 (NDM-1), which poses a global threat to healthcare systems. NDM-1 is an enzyme that renders beta-lactam antibiotics ineffective, leading to antibiotic resistance. The researchers used molecular modeling and simulation techniques to identify two potential small molecule inhibitors, STK115225 and STK107343, that showed stable binding to NDM-1. These inhibitors have the potential to restore the efficacy of beta-lactam antibiotics and combat NDM-1 mediated antibiotic resistance. However, further validation through in vitro and in vivo experiments is needed. [Extracted from the article]

Researchers from Federal University in Seropedica, Brazil have released new data on chemicals and chemistry, specifically focusing on molecular modeling applied to medicinal chemistry over the past 30 years. The study highlights the importance of molecular structure in understanding the mode of action and designing bioactive compounds. Computer-assisted drug design (CADD) has become widely used by pharmaceutical companies in the search for new drugs. The research discusses the evolution of CADD methods, including empirical field and quantum mechanics modeling, quantitative structure-activity relationship (QSAR) methods, molecular docking, virtual screening, and the increasing application of machine learning methods. The study concludes that this history of molecular modeling continues to evolve and contribute to drug design by reducing research time and cost and accelerating the discovery of new bioactive compounds. [Extracted from the article]

Researchers at Kadir Has University in Istanbul, Turkey have conducted a study on the repurposing of known drugs to identify potential selective inhibitors of HDAC6, a promising target for anticancer drugs. The researchers used structure-based virtual screening and molecular modeling techniques to identify four compounds with potential selectivity for HDAC6. These compounds were sourced from various databases and show promise for further investigation as potential anticancer agents. The study was funded by the Health Institutes of Turkey and was published in the journal Heliyon. [Extracted from the article]

A researcher at Adam Mickiewicz University in Poznan, Poland has published a study on the interactions between carbazole derivatives and the G-quadruplex structure formed in the promoter region of the Bcl-2 gene. The Bcl-2 gene is a potential target for anticancer therapy due to its high expression in tumors and resistance to chemotherapy-induced apoptosis. The study used various techniques, including molecular modeling, to investigate the binding affinities and interactions between the carbazole compounds and the G-quadruplex. The results suggest a p-p interaction between the ligands and a guanine tetrad of the Bcl-2 G-quadruplex, with differences in binding strength between the ligands. [Extracted from the article]

A new study conducted by researchers at the Universitat Politecnica de Valencia in Spain explores the fluorescence properties of the topical retinoid adapalene, a dermatological agent used in acne therapy. The study investigates the absorption and emission properties of adapalene in different solvents and biological media, revealing a strong positive solvatochromism for the emission. Molecular modeling and simulations suggest the presence of two quasi-degenerate states, and the study demonstrates the potential of adapalene to act as a biological probe using albumin, DNA, and micelles. This research provides valuable information on the localization and interaction of drugs in the body. [Extracted from the article]

A study conducted at the National Research Centre in Giza, Egypt, has focused on the design, characterization, and applications of a naphthoquinone-based Schiff base and its metal complexes. The research involved the synthesis and characterization of the ligand and its metal complexes using various spectroscopic techniques. Molecular docking studies were also performed to assess the biological activity of the compounds. Experimental applications of the ligand and its metal chelates showed antimicrobial and antioxidant activities. The study provides valuable insights into the potential applications of these compounds in the field of drug development. [Extracted from the article]

A new report discusses research findings on paclitaxel therapy, a chemotherapy treatment for cancer. The research focuses on improving the oral administration of paclitaxel, which has been challenging due to its susceptibility to intestinal P-glycoprotein and cytochrome P450. The study reports the design and evaluation of novel dual inhibitors of P-glycoprotein and CYP3A4, which showed promising results in improving the oral absorption of paclitaxel in mice and rats. The research provides medicinal chemistry advice for resolving concerns with the oral administration of chemotherapeutic agents. [Extracted from the article]

A recent study conducted by researchers at Sunchon National University examined the pharmacokinetic diversity of the antibiotic cefaclor based on genetic polymorphisms in the solute-carrier-family-15-member-1 (SLC15A1) gene. The study aimed to determine if these genetic variations had a significant impact on the effectiveness and stability of cefaclor. The results indicated that there were no significant differences in pharmacokinetics or structural stability based on the genetic polymorphisms in SLC15A1 exons 5 and 16. This suggests that these genetic variations have limited influence on the pharmacokinetic diversity of cefaclor. [Extracted from the article]

A recent study conducted by researchers at Al-Azhar University in Cairo, Egypt, explored the potential of new quinoxaline-sulfonamide derivatives as inhibitors of alpha-glucosidase, alpha-amylase, and acetylcholinesterase enzymes. The derivatives showed promising inhibitory activity against these enzymes, with one derivative, compound 4, exhibiting the most potent activity. The study also included computational analysis and ADMET analysis to further understand the properties and potential of these derivatives. This research provides valuable insights into drug development and may have implications for the treatment of conditions such as diabetes and Alzheimer's disease. [Extracted from the article]

Researchers at Government College University Faisalabad in Pakistan have synthesized a library of biphenyl-4-carboxamide derivatives and tested them for their anticancer, antimicrobial, and enzyme inhibition activities. The compound 4h showed the most activity against human liver cancer cells, while compound 4c demonstrated potent inhibitory activity against acetylcholinesterase and urease enzymes. The synthesized compounds also exhibited antibacterial and antifungal activities. Molecular docking studies revealed that the compounds had good binding capability with the target enzymes. The researchers concluded that these compounds have potential as pharmaceutical agents. [Extracted from the article]

A recent study conducted at the National Research Centre in Giza, Egypt, has explored the enantioseparation and quantitation of certain CNS acting drugs using high-performance liquid chromatography (HPLC). The researchers successfully separated three pairs of enantiomers of antidepressant drugs using chiral stationary phases. The study also utilized molecular docking simulations to better understand the interaction between the enantiomers and the stationary phase. The proposed method shows promise for implementation in quality control laboratories and wastewater analysis for these drugs. [Extracted from the article]

A recent study conducted at the Institute of Chemistry in Hanoi, Vietnam, has successfully synthesized a series of new fluorinated dihydrofurano-naphthoquinone compounds using microwave-assisted multi-component reactions. These compounds were characterized and evaluated for their anti-inflammatory activity in macrophage cells. Several of the compounds showed high inhibitory activity and decreased levels of pro-inflammatory cytokines. Molecular docking simulations and physicochemical computations demonstrated the drug-like characteristics of the synthesized compounds. The study highlights the potential of fluorinated dihydrofurano-naphthoquinone compounds as anti-inflammatory agents. [Extracted from the article]

A recent study conducted at Federal University Goias in Goiania, Brazil, explored the aqueous solubility and intermolecular interactions of diclofenac, a widely used non-steroidal anti-inflammatory drug. The study found that diclofenac's low aqueous solubility and subsequent low bioavailability pose challenges for oral administration. The researchers used molecular modeling techniques to investigate the molecular interactions that influence solubility, including non-polar interactions, dipole interactions, and hydrogen bonding. The study's findings provide insights into the solubility challenges of diclofenac and could contribute to the development of improved drug formulations. The research was supported by various organizations, including Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ). [Extracted from the article]

Researchers at the Medical University of Bialystok in Poland have conducted a study on urinary antiinfectives. The focus of their research was on benzamide trimethoprim derivatives as inhibitors of human dihydrofolate reductase (h DHFR), an enzyme that is essential for cellular function and is a potential target for cancer therapy. The researchers synthesized and evaluated eleven benzamide compounds and found that they were active against h DHFR, with two derivatives, JW2 and JW8, showing the most promise. Molecular modeling studies revealed the interactions between these compounds and the key residues of the enzyme. The researchers concluded that this class of compounds holds great potential for further development in medicinal chemistry. [Extracted from the article]

A study conducted in Maharashtra, India, has synthesized and characterized novel compounds with potential anticancer and antimicrobial properties. The compounds were tested against kidney and lung carcinoma cell lines and showed good inhibition of the kidney carcinoma cell line. Additionally, the compounds exhibited moderate to good antimicrobial activity against bacterial and fungal strains. Molecular docking studies and in-silico target prediction were also conducted to explore the compounds' binding interactions and potential reactivity and toxicity. The study concludes that two of the synthesized compounds, VIf and VIg, show promise for further exploration. [Extracted from the article]

Researchers from Shandong University have conducted a study using molecular modeling and simulation approaches to identify potential molecular targets for burdock inulin in the treatment of autoimmune diseases. The study found that burdock inulin showed good binding affinity for inflammatory proteins such as iNOS, COX-2, TNF-alpha, IL-6, and IL-1b, with IL-1b, COX-2, and iNOS identified as the best targets. The research suggests that further experiments are needed to explore the potential of inulin in targeting iNOS and reducing autoimmune diseases. The study was published in Scientific Reports. [Extracted from the article]

A recent report discusses research conducted at the University of Sargodha in Pakistan on the synthesis, crystal structures, molecular modeling, and biological studies of metal complexes derived from a piroxicam analogue. The complexes were synthesized by coupling the analogue with various metal ions, including Mn (II), Co (II), Ni (II), Cu (II), and Zn (II). Analytical techniques were used to confirm the synthesis of the complexes, and their molecular structures were determined through X-ray crystallography. The compounds showed potential as therapeutic agents based on antioxidant and antibacterial activities, as well as in-silico studies. [Extracted from the article]

A recent study conducted at Hashemite University in Zarqa, Jordan, focused on the synthesis and biological activities of enamino barbiturates as antiproliferative and antimicrobial agents. The researchers synthesized several compounds and characterized their structures using spectroscopic techniques. Molecular docking studies revealed that certain compounds exhibited strong binding affinities with the human estrogen receptor enzyme. Additionally, one compound, 3e, displayed remarkable antifungal activity compared to Fluconazole and Nystatin, with a minimum inhibitory concentration (MIC) of 0.011 mM. The toxicity of the synthesized compounds was found to be better than tamoxifen on MCF-7 cells. Overall, the study suggests the potential of enamino barbiturates as effective drug molecules with antifungal and antiproliferative properties. [Extracted from the article]

A recent study conducted by researchers at Kazan Federal University in Russia explored the role of butyrylcholinesterase (BChE) in the degradation of atropine, an anticholinergic chronotropic agent. The study found that human plasma BChE slowly hydrolyzes atropine, but its affinity for the enzyme is weak. The researchers also investigated the inhibition profiles of BChE for hydrolysis of atropine and another substrate, and found that both substrates are hydrolyzed at the same site. Molecular docking experiments suggested that the L-atropine isomer is the most reactive enantiomer. Overall, the study concluded that plasma BChE likely has no significant role in the metabolism of atropine under current medical conditions. [Extracted from the article]

A study conducted by researchers at Abbottabad University of Science and Technology (AUST) focused on the synthesis and biological assessment of thiazole-thiazolidinone derivatives as potential anti-cancer agents. The researchers confirmed the structure of these derivatives using various characterization techniques. They also evaluated the inhibitory potentials of the derivatives against human cancer cell lines and established a structure-activity relationship. Additionally, the compounds were examined using molecular docking experiments to assess their binding interactions with enzyme active sites. This research provides valuable insights into the development of new anti-cancer drugs. [Extracted from the article]

A study conducted in Tamil Nadu, India, synthesized a new bidentate Schiff base derived from glycine and 3-phenoxybenzaldehyde, along with its metal complexes. The molecular structure of the Schiff base was confirmed using various analytical techniques. The metal complexes showed more potent antimicrobial activity than the Schiff base, particularly the Cu(II) complex. Molecular docking studies suggested that the ligand and its metal complexes have potential therapeutic applications in cancer and diabetes treatment. The research has been peer-reviewed and published in Inorganic Chemistry Communications. [Extracted from the article]

A study conducted at Mustansiriyah University in Baghdad, Iraq, focused on the molecular modeling, synthesis, and pharmacological evaluation of new sulfonamide derivatives as selective inhibitors of carbonic anhydrase XII (CAXII) and IX (CAIX). The researchers synthesized benzene sulfonamide compounds and tested their cytotoxic effect against the AMJ-13 Iraqi breast cancer cell line. The compounds showed potent action against the cell line, with the most effective compounds being numbers 4, 7, and 10. The study concluded that the most active drugs had the highest binding scores in the active site of CAXII and CAIX, which may explain their inhibitory profile. [Extracted from the article]

A recent report from the Institute of Nuclear Chemistry and Technology in Warsaw, Poland discusses the use of tacrine and its derivatives as radiotracers for the diagnosis of Alzheimer's disease. Tacrine is a drug that was previously approved for Alzheimer's disease due to its ability to increase the level of acetylcholine in the central nervous system. The researchers found that radiopreparations based on tacrine or its analogues were able to cross the blood-brain barrier, while those containing a modified tacrine molecule lost this ability. Computer docking studies also revealed how these compounds bind to the active sites of cholinesterase enzymes. This research provides valuable insights into the development of diagnostic tools for Alzheimer's disease. [Extracted from the article]

Researchers from Marmara University in Istanbul, Turkey have conducted a study on the synthesis and anti-cancer properties of new compounds containing a benzothiazole core. The compounds were evaluated for their cytotoxic activities against lung and prostate cancer cell lines, as well as their selectivity on normal cells. Additionally, the compounds were tested for their inhibitory activities on COX-1 and COX-2 enzymes. Molecular docking calculations were performed to understand the binding interactions of the compounds with the enzymes. The study suggests that the compounds may have potential anti-cancer activity through selective inhibition of the COX-2 enzyme. [Extracted from the article]

A recent study conducted at Maharaja Krishnakumarsinhji Bhavnagar University in Bhavnagar, India, explored the synthesis and biological activity of benzimidazole-thiazolidine-4-one compounds. The researchers synthesized a series of these compounds and evaluated their antimicrobial activity against bacterial and fungal strains. They found that certain compounds exhibited significant antibacterial and antifungal activity. Additionally, molecular docking and molecular dynamics simulations were performed to understand the compounds' interactions with E. coli DNA GyrB protein. The study provides insights into the potential therapeutic use of these compounds against bacterial infections. [Extracted from the article]

A recent study conducted by researchers at the University of Aleppo in Syria focused on the synthesis of bis-sulfonamide compounds that inhibit the aromatase enzyme, which plays a crucial role in the biosynthesis of estrogen. The researchers used molecular modeling to identify the most promising compound, which exhibited a high binding energy compared to other compounds and known inhibitors. The synthesized compounds were characterized using various analytical methods. This research provides valuable insights into the development of potential anticancer drugs targeting the aromatase enzyme. [Extracted from the article]

Researchers from Qassim University in Saudi Arabia have published a study on the development of novel antidiabetic agents. They designed and synthesized a series of isoxazolidine-isatin hybrids and evaluated their potential as dual a-amylase and a-glucosidase inhibitors. The most potent compound, 5d, showed impressive inhibitory activity against both enzymes. In silico studies supported the in vitro results, suggesting that compound 5d could be a potential dual inhibitor for the management of diabetes. Further research and optimization of the compound's structure are needed. [Extracted from the article]

A study conducted at Mansoura University in Egypt has discovered new compounds that show potential as inhibitors of EGFR-TK, an enzyme involved in tumor growth. The synthesized compounds were found to be effective against EGFR-TK activity, with three derivatives showing the best inhibitory activities. These compounds were also tested for their cytotoxicity against various cell lines and were found to have multi-inhibitory activities against other kinases. The research suggests that these compounds could be promising candidates for cancer therapy. [Extracted from the article]

A recent study conducted by the Siberian Branch of the Russian Academy of Sciences (SB RAS) has focused on the design and synthesis of new dual inhibitors of tyrosyl-DNA phosphodiesterase 1 and 2 (TDP1 and TDP2) based on deoxycholic acid. These inhibitors have the potential to enhance the effectiveness of topoisomerase poison antitumor therapy. The study found that certain derivatives of deoxycholic acid demonstrated promising inhibitory activity against TDP1 and TDP2 in vitro. Additionally, when combined with low-toxic concentrations of antitumor drugs, these inhibitors showed significantly greater cytotoxicity. The research provides valuable insights into the development of new drugs and therapies for the treatment of tumors. [Extracted from the article]

A study conducted by researchers at the University of Tehran has revealed key structural features for developing new agonists targeting the d opioid receptor (DOR). Opioids are widely prescribed for pain relief but can lead to overdosing and fatalities. The study used a machine learning approach to develop a quantitative structure-activity relationship (QSAR) model, identifying three key structural features that contribute significantly to the model's performance. The research also conducted a molecular docking study to identify essential chemical interactions for designing rational compounds for drug discovery targeting DOR. [Extracted from the article]